Featured Posts
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
National Review
Telehealth Is Less Promising Than It First Seemed
A key issue facing Congress in its postelection, “lame duck” session is whether to extend regulatory flexibilities expiring at year end that make telehealth services more…
Search Posts
Blog
Q&A on the FDA’s New E-Cigarette Rules
After years of waiting and fighting, the new rules put forth by the U.S. Food and Drug Administration (FDA) on electronic cigarettes and other non-cigarette…
Blog
RealClear Radio Hour: War on Cancer
In this week’s episode of RealClear Radio Hour, we tackle the war on cancer. Disruptive innovators, Stephen Bonner and Paul Davies, confront bureaucracy and big…
Blog
Deflate Drug Prices by Reforming the FDA
This Wednesday, the Senate Select Committee on Aging will hold a hearing on “sudden price spikes” among certain off-patent drugs. The most widely publicized of these…
Blog
A Big Payoff for Patient Investors
There’s a fascinating story in The New York Times this week about pharmaceutical companies and the process of discovering new drugs. Fifteen years ago, the…
Study
Compound Fracture
Drug compounding involves reformulating or repackaging approved medicines to better tailor them to patients’ needs. Adding new federal regulations to further restrict compounding would do…
News Release
A Second Federal Court Green-Lights Lawsuit Against Obamacare
WASHINGTON, Oct. 31 – A second federal judge Thursday has ruled a lawsuit that challenges a major IRS Obamacare regulation could proceed despite the government’s…